F-group (family)
4011.1.1.1 AMP-binding
Ligands and drugs
343
Member domains
192
with ligand contacts (≤ 4 Å)
56.0% of members
175
with DrugDomain annotations
51.0% of members
96
with a DrugBank compound
28.0% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 4011.1.1.1 belongs to X-group 4011 beta-barrel domain in acetyl-CoA synthetase-like proteins, which binds 4.4 ligand superclasses per 20 proteins, narrower than 88% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00131 | AMP | Adenosine phosphate | 48 |
| DB00171 | ATP | ATP | 16 |
| DB09459 | TLA | L-tartaric acid | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| AMP | ADENOSINE MONOPHOSPHATE | 48 |
| ATP | ADENOSINE-5'-TRIPHOSPHATE | 17 |
| SLU | 5'-O-[N-(DEHYDROLUCIFERYL)-SULFAMOYL] ADENOSINE | 14 |
| SVS | 5'-deoxy-5'-({[2-(2-hydroxyphenyl)ethyl]sulfonyl}amino)adenosine | 10 |
| 3UK | 5'-O-[(S)-[(2-aminobenzoyl)oxy](hydroxy)phosphoryl]adenosine | 9 |
| MGmetal | MAGNESIUM ION | 9 |
| CL | CHLORIDE ION | 7 |
| NAmetal | SODIUM ION | 6 |
| CAmetal | CALCIUM ION | 5 |
| 9SN | 6-fluoroanthraniloyl-AMP | 4 |
| 4UW | 5'-O-[(R)-hydroxy{[(2E)-3-(5-methoxy-4-oxocyclohexa-1,5-dien-1-yl)prop-2-enoyl]oxy}phosphoryl]adenosine | 3 |
| ANP | PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER | 3 |
| OOB | 5'-O-[(R)-(benzoyloxy)(hydroxy)phosphoryl]adenosine | 3 |
| QA7 | 5'-O-{(S)-hydroxy[(4-methyl-2-oxopentanoyl)oxy]phosphoryl}adenosine | 3 |
| 1HZ | 5'-deoxy-5'-({[2-(2,3-dihydroxyphenyl)ethyl]sulfonyl}amino)adenosine | 2 |
| 8JJ | 5'-O-[(R)-{[(7beta,8alpha,9beta,10alpha,13alpha,16beta)-7,16-dihydroxy-18-oxokauran-18-yl]oxy}(hydroxy)phosphoryl]adenosine | 2 |
| 8K1 | 5'-O-[(R)-hydroxy{[(7beta,8alpha,9beta,10alpha,11beta,13alpha)-7-hydroxy-19-oxo-11,16-epoxykauran-19-yl]oxy}phosphoryl]adenosine | 2 |
| 8Q2 | [(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl ~{N}-[(3~{S})-3-azanyl-3-(4-prop-2-ynoxyphenyl)propanoyl]sulfamate | 2 |
| B1U | 5'-O-[(2-nitrobenzene-1-carbonyl)sulfamoyl]adenosine | 2 |
| B1X | 5'-O-[(3-cyanobenzene-1-carbonyl)sulfamoyl]adenosine | 2 |